TNF receptor p55 controls early acute graft-versus-host disease1

Journal of Immunology

Volumn 158, Issue 11, 1997, Pages 5185-5190

  Speiser, Daniel E ^a   Bachmann, Martin F ^a   Frick, Thomas W ^c   McKall Faienza, Kim ^a   Griffiths, Emily ^a   Pfeffer, Klaus ^d   Mak, Tak W ^b   Ohashi, Pamela S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b AMGEN INSTITUTE   (Canada)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ALLOTRANSPLANTATION; ANIMAL; ARTICLE; BONE MARROW TRANSPLANTATION; C57BL MOUSE; GENETICS; GRAFT VERSUS HOST REACTION; IMMUNOLOGY; MOUSE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; BONE MARROW TRANSPLANTATION; GRAFT VS HOST DISEASE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031155266     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Martin, P. J., J. A. Hansen, R. Storb, and E. D. Thomas. 1987. Human marrow transplantation: an immunological perspective. Adv. Immunol. 40:379.
2. Ferrara, J. L. M., and H. J. Deeg. 1991. Graft-versus-host disease. N. Engl. J. Med. 324:667.
3. Vogelsang, G. B., and A. D. Hess. 1994. Graft-versus-host disease: new directions for a persistent problem. Blood 84:2061.
4. Slavin, R. E., and G. W. Santos. 1973. The grafl-versus-host reaction in man after bone marrow transplantation: pathology, pathogenesis, clinical features and implications. Clin. Immunol. Intnumopathol. 1:472.
5. Storb, R., and E. D. Thomas. 1985. Graft-versus-host disease in dog and man: the Seattle experience. Immunol. Rev. 88:215.
6. Renfconen, R., and P. Häyry. 1987. Cellular infiltrates in the target organs associated with acute graft-versus-host disease. Bone Marrow Transplant. 2:333.
7. Ferrara, J. L. M. 1993. Cytokine dysregulation as a mechanism of graft-versus-host disease. Curr. Opin. Immunol. 5:794.
8. Holler, E., H. J. Kolb, A. Moeller, J. Kempeni, S. Liesenfeld, H. Pechumer, W. Lehmacher, G. Ruckdeschel, B. Gleixner, C. Riedner, G. Ledderose, G. Brehm, J. Mittermueller, and W. Wilmanns. 1990. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 75:1011.
9. Symington, F. W., M. S. Pepe, A. B. Chen, and A. Deliganis. 1990. Serum tumor necrosis factor alpha associated with acute graft-versus-host disease in humans. Transplantation 50:518.
10. Remberger, M., O. Ringden, and L. Markling. 1995. TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD. Bone Marrow Transplant. 15:99.
11. Piguet, P., F, G. E. Grau, B. Allet, and P. Vassalli. 1987. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs-host disease. J. Exp. Med. 166:1280.
12. Beutler, B., and A. Cerami. 1989. The biology of cachectin/TNF: a primary mediator of the host response. Anna. Rev. Immunol. 7:625.
13. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411.
14. Beutler, B., and C. van Huffel. 1994. Unraveling function in the TNF ligand and receptor families. Science 264:667.
15. Tartaglia, L. A., R. F. Weber, I. S. Figari, C. Reynolds, M. A. Palladino, and D. V. Goeddel. 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Nail. Acad. Sci. USA 88:9292.
16. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370: 650.